%19967 0 Activation_of_C3_and_C5 1 Alternative_complement_activation 2 Amyloid_Neuropathies,_Familial 3 Angioedema 3--0 4 Angioedemas,_Hereditary 4--0 5 Atypical_hemolytic_uremic_syndrome 5--0 5--1 6 Choroid_Diseases 6--0 7 Classical_antibody-mediated_complement_activation 7--2 7--3 7--4 8 Complement_cascade 8--2 8--3 8--4 8--5 9 Coxa_Valga 9--1 10 Creation_of_C4_and_C2_activators 10--2 10--3 10--4 11 Fibrous_Dysplasia_of_Bone 11--0 12 Glomerulonephritis,_IGA 12--0 12--1 12--8 13 Glomerulonephritis,_Membranoproliferative 13--0 13--1 13--8 14 Hemolysis 14--0 15 Hemolytic-Uremic_Syndrome 15--0 15--1 15--8 16 Immune_Complex_Diseases 16--0 16--1 16--8 17 Initial_triggering_of_complement 17--2 17--3 17--4 17--5 17--12 17--13 17--16 18 Leukopenia 18--0 18--1 19 Lupus_Erythematosus,_Cutaneous 19--0 19--8 19--17 20 Macular_Degeneration 20--0 20--1 20--8 20--17 21 Meningitis,_Meningococcal 21--0 21--8 22 Mucopolysaccharidosis_VII 22--0 23 Otitis_Media 23--0 23--8 23--17 24 Panniculitis,_Lupus_Erythematosus 24--0 24--8 24--17 25 Purpura,_Schoenlein-Henoch 25--0 25--8 25--17 26 Retinal_Drusen 26--0 26--1 26--8 26--17 27 Terminal_pathway_of_complement 27--14 27--20 27--21 28 Vasculitis,_Leukocytoclastic,_Cutaneous 28--0 28--8 28--17 29 Wet_Macular_Degeneration 29--0 29--1 29--8 29--17